Press Release: Astellas Pharma Announces Completion of Acquisition of Propella Therapeutics

Astellas Pharma Inc. (“Astellas”) announced that it has completed the acquisition of Propella Therapeutics, Inc. (“Propella”) on December 21, 2023, and Propella is now a wholly owned subsidiary of Astellas.